The major constituents of this defense system are tumor antigen-specific cytotoxic T-lymphocytes (CTLs), whose anti-tumor functions are amplified by immune checkpoint blockade antibodies such as CTLA-4 inhibitors and PD-1/PD-L1 inhibitors3–6. This evidence concerns the gene CD274 and neoplasm.